<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01753609</url>
  </required_header>
  <id_info>
    <org_study_id>TULIP-PRT-002-05-B-CTIL</org_study_id>
    <nct_id>NCT01753609</nct_id>
  </id_info>
  <brief_title>Safety and Performance Evaluation of Tulip Device in Healthy Overweight and Obese Volunteers</brief_title>
  <official_title>Safety and Performance Evaluation of TrimWeight Device - an Intragastric Auto-inflating &amp; Degradable Balloon in a Swallow-able Capsule (&quot;the Device&quot;), for Enhancing Satiety and Satiation in Healthy Over Weight and Obese Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tulip Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tulip Medical Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess the safety and performance of an intragastric auto-inflating and
      degradable balloon
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will assess the safety and performance of an intragastric auto-inflating and
      degradable balloon, packed in a swallow-able capsule, in healthy subjects with 30 &lt; BMI≤ 35.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with device related serious adverse events</measure>
    <time_frame>36 days</time_frame>
    <description>Safety will be assessed descriptively by summarizing device related SAEs, gastroscopic examination, daily diary, vital sign measurements, physical examination and abdomen circumference.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of capsule tolerability</measure>
    <time_frame>36 days</time_frame>
    <description>Comfort and tolerability will be assessed by the patient and will be recorded in a daily diary. Tolerability evaluation will include: assessment of swallow ability, gastrointestinal comfort, defecation effort, appetite.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfying evacuation of the balloon from the stomach after oral intake</measure>
    <time_frame>36 days</time_frame>
    <description>Number of subjects showing satisfying evacuation of the balloon from the stomach after oral intake by means of a gastroscopic examination</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Over Weight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Tulip capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>swallowing Tulip capsule for up to 29 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tulip capsule</intervention_name>
    <description>swallowing Tulip capsule for up to 29 days</description>
    <arm_group_label>Tulip capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21 ≤ Age &lt;65 years

          -  30 &lt; BMI ≤ 35 kg/m2

          -  Healthy without any medication;

          -  No history of weight reduction of more than 5% of total body weight in the past 6
             months;

          -  Normal blood count and chemistry;

          -  Hemoglobin level over 11;

          -  At least 3 bowel movements per week;

          -  Subject declares that he/she is able to go through gastroscopic examination;

          -  Subject is able and willing to give informed consent and follow protocol procedures.

        Exclusion Criteria:

          -  Any history or evidence of significant cardiac, renal, neurologic, metabolic,
             pulmonary, gastrointestinal, hematologic abnormality, chronic hepatic disease or any
             other disease which in the judgment of the investigator would interfere with the study
             or confound the results;

          -  History or evidence of any active liver disease. (abnormal liver functions: &gt;1.5 times
             upper limit);

          -  History or symptoms of thyroid disease which is not controlled by medication;

          -  Abnormal gastrointestinal findings: Diaphragmatic hernia &gt; 3 cm; Active peptic ulcer;
             Erosive gastritis; Gastric outlet obstruction;

          -  Subject with IBD

          -  Significant swallowing disorders;

          -  Past history of any gastrointestinal surgery (excluding uncomplicated appendectomy);

          -  Malabsorption disorders.

          -  Is taking medications that reduce gastric acidity

          -  Currently using pharmaceutical agents or food supplements for weight loss;

          -  History of or current eating disorder such as anorexia or bulimia or compulsory
             overeating.

          -  History of food Allergy;

          -  Subject with poor venous access;

          -  Is taking chronic aspirin or other non-steroidal anti-inflammatory agents, or other
             medications known to be gastric irritants;

          -  Have any coagulation problem and/or taking any anticoagulant medications;

          -  Evidence of current malignant disease;

          -  Have history of any acute disease (viral, bacterial, pain, accident) in the last 6
             weeks.

          -  Female subject who are breastfeeding or have a positive pregnancy test at screening or
             at any time during the study;

          -  Inability to give written informed consent;

          -  History of alcohol or drug abuse within 6 months of screening;

          -  Mental disorders;

          -  Currently participating in an ongoing clinical study

          -  Any reasons making the patient a poor candidate in the opinion of the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sigal Fishman, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sigal Fishman, Dr.</last_name>
    <phone>972-3-6974469</phone>
    <email>sigalf@tlvmc.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tair Lapidot, Dr.</last_name>
    <phone>972-72-2505995</phone>
    <phone_ext>105</phone_ext>
    <email>tair@tulipmed.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center , Gastroenterology - Institute</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sigal Fishman, Dr.</last_name>
      <phone>972-3-6974469</phone>
      <email>sigalf@tlvmc.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Sara Pel</last_name>
      <phone>972-3-6974469</phone>
      <email>sarap@tlvmc.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ron Yishai, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2012</study_first_submitted>
  <study_first_submitted_qc>December 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2012</study_first_posted>
  <last_update_submitted>December 17, 2012</last_update_submitted>
  <last_update_submitted_qc>December 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Over weight</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

